ATE135910T1 - Verwendung von (1r,2r)-n-methyl-2-(3-pyridyl)-2- tetrahydrothiopyrancarbothioamid-1-oxid zur herstellung von arzneimitteln zur behandlung von koronarschwäche - Google Patents

Verwendung von (1r,2r)-n-methyl-2-(3-pyridyl)-2- tetrahydrothiopyrancarbothioamid-1-oxid zur herstellung von arzneimitteln zur behandlung von koronarschwäche

Info

Publication number
ATE135910T1
ATE135910T1 AT90403060T AT90403060T ATE135910T1 AT E135910 T1 ATE135910 T1 AT E135910T1 AT 90403060 T AT90403060 T AT 90403060T AT 90403060 T AT90403060 T AT 90403060T AT E135910 T1 ATE135910 T1 AT E135910T1
Authority
AT
Austria
Prior art keywords
pyridyl
methyl
oxide
treatment
tetrahydrothiopyrancarbothioamide
Prior art date
Application number
AT90403060T
Other languages
English (en)
Inventor
Icilio Cavero
Serge Mondot
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Application granted granted Critical
Publication of ATE135910T1 publication Critical patent/ATE135910T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT90403060T 1989-10-31 1990-10-30 Verwendung von (1r,2r)-n-methyl-2-(3-pyridyl)-2- tetrahydrothiopyrancarbothioamid-1-oxid zur herstellung von arzneimitteln zur behandlung von koronarschwäche ATE135910T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8914272A FR2653662B1 (fr) 1989-10-31 1989-10-31 Application du n-methyl (pyridyl-3)-2 tetrahydrothiopyranne-carbothioamide-2-oxyde-1 a la preparation de medicaments destines au traitement de l'insuffisance coronarienne.

Publications (1)

Publication Number Publication Date
ATE135910T1 true ATE135910T1 (de) 1996-04-15

Family

ID=9386962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90403060T ATE135910T1 (de) 1989-10-31 1990-10-30 Verwendung von (1r,2r)-n-methyl-2-(3-pyridyl)-2- tetrahydrothiopyrancarbothioamid-1-oxid zur herstellung von arzneimitteln zur behandlung von koronarschwäche

Country Status (17)

Country Link
US (1) US5426117A (de)
EP (1) EP0429324B1 (de)
JP (1) JPH03153683A (de)
KR (1) KR910007524A (de)
AT (1) ATE135910T1 (de)
AU (1) AU637419B2 (de)
CA (1) CA2028986A1 (de)
DE (1) DE69026204T2 (de)
DK (1) DK0429324T3 (de)
ES (1) ES2084679T3 (de)
FR (1) FR2653662B1 (de)
GR (1) GR3019441T3 (de)
HU (1) HU212502B (de)
IE (1) IE72476B1 (de)
IL (1) IL96161A (de)
PT (1) PT95757B (de)
ZA (1) ZA908678B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100373173B1 (ko) * 1996-11-18 2003-08-19 주식회사 코오롱 차광성 및 성형성이 우수한 폴리에틸렌테레프탈레이트 수지 조성물
KR102068928B1 (ko) * 2019-05-17 2020-01-21 민은홍 광고수단으로 전환사용이 가능한 레일 조명

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2528849B1 (fr) * 1982-06-17 1985-06-21 Rhone Poulenc Sante Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
IL96161A0 (en) 1991-07-18
JPH03153683A (ja) 1991-07-01
ES2084679T3 (es) 1996-05-16
ZA908678B (en) 1991-08-28
EP0429324A2 (de) 1991-05-29
FR2653662A1 (fr) 1991-05-03
AU6554790A (en) 1991-05-09
IE72476B1 (en) 1997-04-23
HU906946D0 (en) 1991-05-28
IE903901A1 (en) 1991-05-08
HUT59312A (en) 1992-05-28
PT95757A (pt) 1991-09-13
CA2028986A1 (fr) 1991-05-01
PT95757B (pt) 1997-09-30
EP0429324B1 (de) 1996-03-27
FR2653662B1 (fr) 1994-05-13
IL96161A (en) 1996-12-05
DE69026204T2 (de) 1996-09-05
US5426117A (en) 1995-06-20
EP0429324A3 (en) 1992-05-27
GR3019441T3 (en) 1996-06-30
HU212502B (en) 1996-07-29
AU637419B2 (en) 1993-05-27
KR910007524A (ko) 1991-05-30
DE69026204D1 (de) 1996-05-02
DK0429324T3 (da) 1996-04-29

Similar Documents

Publication Publication Date Title
ATE136030T1 (de) Azaheterocyclylmethyl-chromane als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
NO905264D0 (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
DE3867408D1 (de) Maschine zur herstellung von nahrungsmittelprodukten.
DE69113386D1 (de) Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
DE69121561D1 (de) Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DK0443848T3 (da) Nyt antiulcermiddel
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ATE135910T1 (de) Verwendung von (1r,2r)-n-methyl-2-(3-pyridyl)-2- tetrahydrothiopyrancarbothioamid-1-oxid zur herstellung von arzneimitteln zur behandlung von koronarschwäche
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
ATE146077T1 (de) Serotonin-antagonisten zur behandlung von wunden
DE3751510D1 (de) Düse zur Behandlung von Fäden.
ATE176477T1 (de) Neue phospholipidderivate
DE58906618D1 (de) Strobilurinderivate, ihre Herstellung und Verwendung.
ATE139696T1 (de) Verwendung von benzothiazepinen zur herstellung von arzneimitteln zur behandlung von epileptischen anfällen
DE3880110D1 (de) Herstellung von m-aminophenol.
DE69313534D1 (de) Digitoxigenin und Dihydrodigitoxigenin 3-beta-Derivate und pharmazeutische Präparate davon, zur Behandlung von hypertonie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee